PINL:GRPOF - Post by User
Post by
equity4481on May 11, 2021 7:56am
244 Views
Post# 33171918
Reborn1 recap
Reborn1 recapThis is the trial which is front and center from an SP standpoint. The trial commenced on May 5 and runs for 8-10 weeks, so results and progress would be from now to completion in mid-July
I do not believe that this trial was started blind by TBP. They have tested the product strength, efficacy and effectiveness and believe it is an effective opiod replacement. And if that belief is backed up by the FDA, imagine the global change in pain management, never mind the company share value!
So based upon the company financials and a cash burn rate of $2.5M/month, the company currently has (with the May 10 bought deal) approximately 10 months cash o/h to fund the trials commencing.